Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$26,768,272
+$970,630 QoQ
Shares Held
73,921
+0.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#322
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Capital Management, LLC holds $495,472,264 across 11 Drug Manufacturers - General names. AMGN ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
526,560 | $133,730,443 | |
| 2 | ABBV |
AbbVie Inc.
|
505,318 | $127,158,221 | |
| 3 | PFE |
Pfizer Inc
|
2,703,246 | $65,094,163 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,029,843 | $59,339,553 | |
| 5 | LLY |
ELI LILLY & Co
|
38,507 | $46,186,454 | |
| 6 | AMGN |
Amgen Inc
This page
|
73,921 | $26,768,272 | |
| 7 | MRK |
Merck & Co., Inc.
|
179,565 | $23,074,102 | |
| 8 | NVS |
Novartis AG
|
57,958 | $9,083,177 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,768,272 | 73,921 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $25,797,642 | 73,320 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $23,505,440 | 71,814 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $19,996,974 | 70,861 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $19,200,154 | 68,766 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $20,076,282 | 64,440 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $15,286,275 | 58,649 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,793,080 | 55,222 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,610,779 | 53,163 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $14,664,088 | 51,576 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,241,078 | 4,309 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $573,921 | 2,585 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $660,461 | 2,732 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $577,282 | 2,198 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $507,375 | 2,251 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $526,501 | 2,164 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $540,225 | 2,234 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $570,748 | 2,537 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $914,182 | 4,299 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,612,006 | 47,639 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $14,277,215 | 57,382 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $12,127,590 | 52,747 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,256,492 | 44,289 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $7,676,299 | 32,546 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $2,509,189 | 12,377 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||